Unit

Laboratory of Biomaterials for Immunoengineering

Laboratory

Summary

The Biomaterial Laboratory for Immunoengineering at EPFL, led by Dr. Li Tang, focuses on immunoengineering to develop safe and effective therapies against cancer and infectious diseases. Their research program includes reprogramming immune cell metabolism, achieving tissue-specific immune modulation, and manipulating mechanical properties for enhanced immunotherapy.

Official source

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Laboratory of Biomaterials for Immunoengineering

Chat with Graph Search

Exploration and modulation of mechanical cues for enhanced cancer immunotherapy

Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy

Development of cysteine cathepsin inhibitors combined with cell type-specific delivery for the treatment of B-cell lymphoma and solid tumors